Literature DB >> 21458533

Polymorphisms of brain-derived neurotrophic factor associated with heroin dependence.

W Jia1, J G Shi, B Wu, L Ao, R Zhang, Y S Zhu.   

Abstract

Brain-derived neurotrophic factor (BDNF) promotes synaptic remodeling and modulates the function of other neurotransmitters. It also plays a role in the reward response to many drugs, including heroin. To identify genetic variants associated with heroin dependence, we compared four single nucleotide polymorphisms (SNPs, rs13306221, rs6265, rs56164415, and rs16917204) of the BDNF gene in 487 subjects with heroin dependence and 492 healthy individuals. The analysis revealed the G allele of rs6265 was significantly more common in heroin-dependent subjects than in the healthy controls (P=0.001 after Bonferroni correction). Among heroin-dependent individuals, the onset of dependence was significantly earlier in individuals with GG or GA genotypes compared to AA individuals (P<0.01). Additionally, we found that the G allele of rs13306221 was significantly more frequent in heroin-dependent subjects than in controls (P=0.005 after Bonferroni correction). These findings support a role of BDNF rs6265 and rs13306221 polymorphisms in heroin dependence and may guide future studies to identify other genetic risk factors for heroin dependence.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458533     DOI: 10.1016/j.neulet.2011.03.072

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

Review 1.  Exercise as a novel treatment for drug addiction: a neurobiological and stage-dependent hypothesis.

Authors:  Wendy J Lynch; Alexis B Peterson; Victoria Sanchez; Jean Abel; Mark A Smith
Journal:  Neurosci Biobehav Rev       Date:  2013-06-24       Impact factor: 8.989

Review 2.  Genetics of opiate addiction.

Authors:  Brian Reed; Eduardo R Butelman; Vadim Yuferov; Matthew Randesi; Mary Jeanne Kreek
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

Review 3.  A review of opioid addiction genetics.

Authors:  Richard C Crist; Benjamin C Reiner; Wade H Berrettini
Journal:  Curr Opin Psychol       Date:  2018-08-09

Review 4.  Aerobic exercise as a promising nonpharmacological therapy for the treatment of substance use disorders.

Authors:  Gigliola Marrero-Cristobal; Ursula Gelpi-Dominguez; Roberto Morales-Silva; John Alvarado-Torres; Joshua Perez-Torres; Yobet Perez-Perez; Marian Sepulveda-Orengo
Journal:  J Neurosci Res       Date:  2021-12-01       Impact factor: 4.433

5.  Sign-tracking to an appetitive cue predicts incubation of conditioned fear in rats.

Authors:  Jonathan D Morrow; Benjamin T Saunders; Stephen Maren; Terry E Robinson
Journal:  Behav Brain Res       Date:  2014-04-18       Impact factor: 3.332

6.  The Role of Neurotrophins in Major Depressive Disorder.

Authors:  Cheng Jiang; Stephen R Salton
Journal:  Transl Neurosci       Date:  2013-03-01       Impact factor: 1.757

Review 7.  Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic.

Authors:  Rajiv Balyan; David Hahn; Henry Huang; Vidya Chidambaran
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-02-24       Impact factor: 4.481

Review 8.  Glial neuroimmune signaling in opioid reward.

Authors:  Hong Zhang; Tally M Largent-Milnes; Todd W Vanderah
Journal:  Brain Res Bull       Date:  2019-11-29       Impact factor: 4.077

9.  The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese heroin-dependent patients.

Authors:  Shiou-Lan Chen; Sheng-Yu Lee; Yun-Hsuan Chang; Tzu-Yun Wang; Shih-Heng Chen; Chun-Hsien Chu; Po See Chen; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Sci Rep       Date:  2015-02-02       Impact factor: 4.379

Review 10.  Advances in genetic studies of substance abuse in China.

Authors:  Yan Sun; Shiqiu Meng; Jiali Li; Jie Shi; Lin Lu
Journal:  Shanghai Arch Psychiatry       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.